Anti-CD5 antibodies

Details for Australian Patent Application No. 2009287164 (hide)

Owner Symphogen A/S

Inventors Klitgaard, Josephine L. K.; Pyke, Charles; Pedersen, Mikkel Wandahl; Koefoed, Klaus

Agent Spruson & Ferguson

Pub. Number AU-A-2009287164

PCT Pub. Number WO2010/022737

Priority PA 2008 01191 29.08.08 DK; 61/093,700 02.09.08 US

Filing date 28 August 2009

Wipo publication date 4 March 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/022737 Priority application(s): WO2010/022737

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009287165-Method for cloning avian-derived antibodies

2009287163-Recombinant anti-Epidermal Growth Factor Receptor antibody compositions